Yiwu Yandong E-commerce Trading Company – Trademark Portfolio

Entity Type: 99

Yiwu Yandong E-commerce Trading Company holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include UVXOV. The owner is based in Jinhua City.

Room 401, Unit 3, Building 8, Fucheng Community,

Yiwu City Street, Zhejiang Province

Jinhua City 321000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

UVXOV
UVXOV
Registered 2025

Trademark Classifications

Yiwu Yandong E-commerce Trading Company's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Yiwu Yandong E-commerce Trading Company have?

Yiwu Yandong E-commerce Trading Company has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Yiwu Yandong E-commerce Trading Company file in?

Yiwu Yandong E-commerce Trading Company files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Yiwu Yandong E-commerce Trading Company's most well-known trademarks?

Yiwu Yandong E-commerce Trading Company's registered trademark portfolio includes well-known marks such as UVXOV. These are among 1 currently registered trademark in the portfolio.

What is Yiwu Yandong E-commerce Trading Company's trademark registration success rate?

Yiwu Yandong E-commerce Trading Company has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.